Latest News about JNJ
Recent news which mentions JNJ
From Motley Fool
What 13 Analyst Ratings Have To Say About Johnson & Johnson
April 02, 2025
Tickers
JNJ
From Benzinga
From Benzinga
Newsmax, Waton Financial, Johnson & Johnson, Hims & Hers Health, Tesla: Why These 5 Stocks Are On Investors' Radars Today
April 01, 2025
From Benzinga
Johnson & Johnson Stock Is Tumbling Tuesday: What Going On?
April 01, 2025
From Benzinga
From Benzinga
From Benzinga
US Judge Rejects Another Johnson & Johnson Attempt To Use Bankruptcy For Talc Cancer Claims
April 01, 2025
From Benzinga
2 Value Stocks I'm Buying Right Now
April 01, 2025
From Motley Fool
Value Stocks Gain Ground As Inflation, Recession Fears Grow: 4 ETFs To Capitalize On The Trend
March 31, 2025
From Benzinga
Is Hims & Hers Stock Too Cheap to Pass Up?
March 29, 2025
From Motley Fool
3 Relatively Safe Stocks to Buy Right Now
March 29, 2025
From Motley Fool
From Motley Fool
2 Recession-Proof Dividend Stocks to Buy and Hold
March 27, 2025
From Motley Fool
From Benzinga
From Benzinga
FDA Approves Johnson & Johnson's Tremfya For Crohn's Disease
March 21, 2025
From Benzinga
From Benzinga
Johnson & Johnson's Golden Cross: Technical Momentum Meets Groundbreaking Lung Cancer Breakthrough
March 20, 2025
Tickers
JNJ
From Benzinga
From Motley Fool
Alpha Cognition Is 'Under-Followed' As Alzheimer Drug Targets $2 Billion Long Term Care Market: Analyst
March 18, 2025
From Benzinga
FDA Grants Fast Track Review To Johnson & Johnson's Nipocalimab For Autoimmune Disorder That Affects Tears, Saliva
March 18, 2025
From Benzinga
Cancer-Focused Nanobiotix Adjusts $2.7 Billion Johnson & Johnson Agreement To Strengthen Finances And Relieve Funding Burden
March 18, 2025
From Benzinga
From Motley Fool
From Motley Fool
Coinbase, Apple And Robinhood Are Among Top Large-Cap Losers Last Week (Mar 10-Mar 14): Are The Others In Your Portfolio?
March 16, 2025
From Benzinga
Allegations of Inflated Prescription Drug Costs Spark Employee Lawsuit Against JPMorgan
March 15, 2025
From Benzinga
From Motley Fool